Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Contact person: Anila Kreku
E-mail: anila.kreku@dhsc.gov.uk
NUTS: UKI32
Internet address(es)
Main address: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Address of the buyer profile: https://www.gov.uk/government/organisations/department-of-health-and-social-care
I.3) Communication
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
DHSC: GPH: Fleming Fund Managing Agent - Market Engagement
II.1.2) Main CPV code
75211200
II.1.3) Type of contract
Services
II.1.4) Short description
The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement.
II.1.5) Estimated total value
Value excluding VAT:
1.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
85100000
II.2.3) Place of performance
NUTS code:
UKI32
II.2.4) Description of the procurement
The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement. <br/><br/>There Authority will host a will be a market engagement day on 20 March 2025 from 10:00 - 12:00. <br/>Interested attendees are required to RSVP by 17:00 on 18th March 2025.
II.2.14) Additional information
This will be a virtual event. <br/><br/>Clarification questions are permitted until 14th March 2025.<br/><br/>The budget for Phase III of the Fleming Fund is yet to be finalised, it is anticipated that the budget will be similar to Phase I and Phase II, however the Authority will confirm at later market engagement events.
II.3) Estimated date of publication of contract notice:
01/09/2025
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section VI: Complementary information
VI.5) Date of dispatch of this notice
21/02/2025